Kathleen Rickard
Chief Tech/Sci/R&D Officer chez VERONA PHARMA PLC
Fortune : 17 M $ au 31/03/2024
Profil
Kathleen Rickard is currently the Chief Medical Officer at Verona Pharma Plc since 2019.
Prior to this, she worked at Aerocrine AB from 2011 to 2019 as the Chief Medical & Compliance Officer.
She also worked at GSK Plc as the VP-Clinical Development & Medical Affairs.
Dr. Rickard holds a doctorate degree from Hahnemann University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VERONA PHARMA PLC
1,80% | 05/02/2024 | 8 656 336 ( 1,80% ) | 17 M $ | 31/03/2024 |
Postes actifs de Kathleen Rickard
| Sociétés | Poste | Début |
|---|---|---|
| VERONA PHARMA PLC | Chief Tech/Sci/R&D Officer | 01/02/2019 |
Anciens postes connus de Kathleen Rickard
| Sociétés | Poste | Fin |
|---|---|---|
| AEROCRINE AB | Compliance Officer | 01/01/2019 |
| GSK PLC | Corporate Officer/Principal | - |
Formation de Kathleen Rickard
| Hahnemann University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| VERONA PHARMA PLC | Health Technology |
| Entreprise privées | 1 |
|---|---|
Aerocrine AB
 Aerocrine AB Electronic Equipment/InstrumentsElectronic Technology Aerocrine AB operates as a specialty pharmaceutical company focused on respiratory disease. The company was founded by Lars E. Gustafsson, Jon Lundberg, Kjell Alving, and Eddie Weitzberg in November 1997 and is headquartered in Uppsala, Sweden. | Electronic Technology |
